載入...

Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.

Current evidence suggests that administration of 1,25(OH)2D3 to patients with chronic renal insufficiency results in suppression of secondary hyperparathyroidism only if hypercalcemia occurs. However, since the parathyroid glands possess specific receptors for 1,25(OH)2D3 and a calcium binding prote...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Slatopolsky, E, Weerts, C, Thielan, J, Horst, R, Harter, H, Martin, K J
格式: Artigo
語言:Inglês
出版: 1984
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC425405/
https://ncbi.nlm.nih.gov/pubmed/6549016
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!